H1 2020 trading in Benchmark’s Genetics division was resilient in face of challenges posed by the pandemic, while in Advanced Nutrition recent difficulties were compounded by the shrimp sector’s exposure to the food service industry. The ongoing restructuring and cost containment program, targeting £10m+ of annual savings, are being enacted under the guidance of a newly appointed aquaculture specialist as CEO. Factoring in disposals and efficiencies, our new forecasts indicate liquidity remains well within its NOK bond-lending covenant terms. A key near term focus includes preparation for launch of BMK’s innovative sea lice treatment of CleanTreat® + BMK08, providing game-changing revenue prospects.
03 Jun 2020
Streamlined for growth and efficiency
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Streamlined for growth and efficiency
Benchmark Holdings Plc (BMK:LON) | 43.2 0.1 0.6% | Mkt Cap: 319.9m
- Published:
03 Jun 2020 -
Author:
Emma Ulker -
Pages:
17
H1 2020 trading in Benchmark’s Genetics division was resilient in face of challenges posed by the pandemic, while in Advanced Nutrition recent difficulties were compounded by the shrimp sector’s exposure to the food service industry. The ongoing restructuring and cost containment program, targeting £10m+ of annual savings, are being enacted under the guidance of a newly appointed aquaculture specialist as CEO. Factoring in disposals and efficiencies, our new forecasts indicate liquidity remains well within its NOK bond-lending covenant terms. A key near term focus includes preparation for launch of BMK’s innovative sea lice treatment of CleanTreat® + BMK08, providing game-changing revenue prospects.